Anesthetic Management of Deep Hypothermic Circulatory Arrest for Cerebral Aneurysm Clipping

Received from the Departments of Anesthesia and Perioperative Care, Neurological Surgery, and Neurology, and the Center for Cerebrovascular Research, University of California, San Francisco, San Francisco, California.ADVANCES in both neurosurgical and anesthetic techniques have considerably improved the surgical treatment of cerebral aneurysms. 1,2In parallel, endovascular treatment has gained progressively greater acceptance in the last 10 yr. 3However, there remains a small subset of patients in whom conventional neurosurgical approaches still carry an exceptionally high morbidity and mortality. The use of deep hypothermic circulatory arrest (DHCA) in well-selected patients offers a reasonable risk-to-benefit profile when compared with the natural history of the untreated disease.The DHCA approach is not new. 4,5Renewed enthusiasm for this technique as a modality of treatment for complex cerebral aneurysms that are not amenable to traditional surgical or endovascular techniques has been fostered by recent advances in cardiopulmonary bypass technology. 7–10This article will briefly review the rationale for DHCA in the setting of cerebral aneurysm treatment. We will then use the main aspects of the protocol practiced by the senior author (WLY), as a point of departure to review the issues regarding anesthetic and perioperative management.The ability to temporarily eliminate or reduce blood flow into an aneurysm gives the surgeon an important advantage—without flow, an aneurysm is converted from a hard, pulsating mass into a soft, collapsed sac, allowing more aggressive manipulation of the aneurysm to complete its dissection. With most aneurysms, temporary occlusion of the proximal parent artery or arteries will effectively control blood flow into the lesion. With large or complex aneurysms, the aneurysm mass may prevent optimal visualization and clip application to the neck. Collapse of the aneurysm mass creates more working space for dissection and precise clip application.Deep hypothermic circulatory arrest is used for aneurysms that cannot be adequately controlled by conventional surgical or endovascular techniques. Aneurysms in the anterior circulation are, in general, accessible enough to be managed with temporary clipping. Aneurysms that defy conventional treatment are typically in the posterior circulation and large (10–25 mm in diameter) or giant (>25 mm in diameter) in size. 11Often these aneurysms cannot be collapsed easily because of the breadth of the neck, the complexity of the arterial branches at the base, the presence of thrombus or endovascular coils in the lumen, artheroma or calcium in the walls, and fusiform configuration. These anatomic features make direct clipping more difficult and lower the efficacy of conventional techniques. The surgeon's ability to manage these anatomic factors is directly related to operative exposure. When proximal and distal arteries are inaccessible with these complex aneurysms, DHCA may provide the only safe and effective means of vascular control. Deep hypothermic circulatory arrest should be considered an option of last resort for these unusual aneurysms, when all conventional techniques have failed or have been carefully considered. Rarely, DHCA has also been proposed or described for other central nervous system lesions, such as tumors 8or arteriovenous malformations, 12but this discussion is not within the scope of this article.The logistics for neurosurgical DHCA require careful planning and excellent communication. There may be multiple healthcare personnel involved in the perioperative care, including but not limited to anesthesiologists, neurosurgeons, cardiac surgeons, neurologists, cardiologists, intensivists, nurses, and perfusionists.Preoperative preparation includes assessing the power capabilities (including availability of both normal and emergency outlets) of all operating room electrical circuits to meet the extremely large perioperative power demands required to operate all required anesthesia equipment, (the cardiopulmonary bypass machine, the neurosurgical operating microscope, and video display monitors).Preoperative evaluation of the patient should include evaluation of cardiovascular disease that might contraindicate femoral cannulation. If significant aortic insufficiency is present, median sternotomy and left ventricular venting may be required for safe conduct of cardiopulmonary bypass (CPB).Before induction of general anesthesia, arterial line placement is facilitated by the judicious use of local anesthetics, anxiolytics, and narcotics. Oversedation of a patient with altered sensorium from subarachnoid hemorrhage (SAH) may increase the risk of aspiration or, by affecting oxygenation and ventilation, may increase intracranial pressure. Calcium channel blockers are frequently used in the preoperative medication of patients harboring ruptured intracranial aneuryms, 13and some practices use them as a prophylactic measure even for unruptured lesions. 14Anesthesia is induced with an intravenous sedative-hypnotic and a relatively generous dose of narcotics (e.g. , fentanyl 10–50 μg/kg). Use of benzodiazepines such as midazolam during the peri-induction period may minimize the potential for intraoperative recall. Tracheal intubation is facilitated with a nondepolarizing muscle relaxant and ventilation is adjusted to provide a Paco2in the 32–34 mmHg range. To minimize the risk or consequences of air embolism (either from extracorporeal circulation or neurosurgical exposure), nitrous oxide is not administered and a low-dose volatile anesthetic is titrated to maintain amnesia and hemodynamic stability. Hemodynamic management before the initiation of cardiopulmonary bypass is focused on maintaining a cerebral perfusion pressure within ± 10–15% of the preoperative range.For intraoperative management and monitoring, large bore peripheral intravenous access is obtained, a pulmonary artery catheter is placed, external defibrillator pads are applied, and a transesophageal echocardiography (TEE) probe and a bladder catheter are inserted. The patient is temporarily turned into the lateral position to place a spinal subarachnoid drainage system. Then, the patient is positioned to allow surgical access to the head as well as both inguinal regions and, if necessary, the chest for median sternotomy. The majority of aneurysms may be accessed by approaches that are routinely performed in the supine position (e.g. , orbitozygomatic or transpetrosal approach). It is possible to perform a far-lateral craniotomy for which the head and shoulders are positioned in the “3/4 prone” position and the torso is rotated so that the groin is close to supine. Using positioning other than supine, however, might make access to the chest for median sternotomy more difficult. (Should this become necessary). The head is locked in rigid pin fixation according to the neurosurgical approach. Temperature probes are placed against the tympanic membrane, nasopharynx, axilla, and rectum. Scalp electroencephalogram (EEG) is monitored using a 2-channel (bihemispheric) montage. Mannitol (0.5–1 g/kg) can be given for brain relaxation once the craniotomy is underway.During craniotomy and dural opening, platelet-rich plasma and red blood cells can be harvested for postbypass reinfusion to aid in the return of normal coagulation status. Euvolemia is maintained by replacing the amount of blood withdrawn with an equal volume of albumin. A baseline kaolin activated coagulation time (ACT) is drawn to guide heparinization. After dural opening, a temperature probe (Mon-a-Therm, Mallinckrodt, St. Louis, MO) is placed directly into the exposed cortex (hemispheric cortex for carotid territory exposures or cerebellar cortex for posterior approaches).During the period just before CPB, thiopental or propofol is titrated in small (50–100 mg) doses to achieve burst-suppression pattern on the raw EEG signal. A continuous infusion is established to maintain the EEG pattern during normothermia. 15Once cooling begins, the infusion is left constant at the normothermic rate. Alpha-stat Paco2management is used. During circulatory arrest, the drug infusion used for EEG burst-suppression is interrupted and then restarted at the same rate during rewarming.The aneurysm is dissected free as much as possible during spontaneous circulation. Dissection time varies greatly depending on the surgical approach, but typically 2 or 3 h after the craniotomy begins, CPB can be established. Before cannulation, heparin 300 U/kg is administered intravenously via a central venous line. After intravascular mixing is complete (1–2 min), an ACT is measured to ensure adequate heparinization, with the goal of an ACT ≥ 400 sec (or three times the control value). Adequacy of muscle relaxation is confirmed and additional doses of muscle relaxant, fentanyl, and midazolam are administered to counteract the dilutional effect of CPB initiation.After the common femoral artery and vein are cannulated by percutaneous cannulation or direct surgical cutdown, and the position of the venous cannula at the level of the right atrium is confirmed with transesophageal echocardiogram, cardiopulmonary bypass is initiated. Fluid loading and a phenylephrine infusion assist in maintaining bypass flow at 2.5 L·min−1m−2with a mean arterial pressure of approximately 50 mmHg. Once adequate flow is achieved, systemic hypothermia is induced by cooling the oxygenated blood through the extracorporeal exchanger. Once ventricular fibrillation occurs, potassium is given through the right atrial port of the pulmonary artery catheter to achieve asystole. Usually less than three boluses of 20 mEq are necessary. When the brain temperature reaches 15°C, the circulation is arrested and blood is drained through the venous cannula until the cerebral vasculature appears relaxed. Too much drainage can result in a negative pressure gradient with the consequences of air embolism and perhaps the tearing of small fragile perforating vessels emanating from the aneurysm dome or parent vessels.After circulatory arrest, aneurysm clipping may proceed. An occasional beat occurs even during circulatory arrest, which can be a problem if continued cardiac ejection causes significant vascular movement in the operative field. After the aneurysm is secured, CPB is slowly reestablished and extracorporeal blood flows and systemic cardiovascular pressures are monitored to test the repair and assess hemostasis. If further periods of circulatory arrest are deemed necessary, hypothermic flow can be reinstituted until the systemic venous oxygen saturation returns to near the prearrest level. Based on theoretical and practical considerations, 1645 min is thought to be a safe upper limit of total arrest time, but shorter periods are usually used. When the neurosurgeon believes optimal clip placement has been achieved, CPB is resumed and rewarming commences.Nitroprusside (with or without some use of potent volatile anesthetic agents) may be used to control arterial vascular resistance and arterial blood pressure. Spontaneous cardiac rhythm usually reappears between 20 and 26°C. If present, ventricular fibrillation may be electrically cardioverted. In patients without any cardiac comorbidity, inotropes are rarely needed to wean the patient from CPB. After separation from CPB, heparin is reversed with protamine (0.75 mg protamine per 100 U heparin initially administered). Initial post-CPB hematocrit, platelet count, and coagulation studies (e.g. , PT, aPTT, fibrinogen, etc .) are obtained to guide further therapy for disturbances of hemostasis after cardiopulmonary bypass. Autologous blood removed before CPB may be returned to the patient and the pump perfusate is concentrated and administered. An additional ACT is measured to confirm complete heparin reversal (ACT < 150 or within 10% of baseline value). Additional protamine is administered, if necessary, to counteract remaining heparin effect. Based on the clinical context, blood products are administered to correct any coagulopathies.The patient is transported to the intensive care unit with cardiovascular monitoring and remains intubated and mechanically ventilated until return of adequate sensorium, ventilatory parameters, and muscle strength for extubation of the trachea. This might be within 3 or 4 h if propofol is used to induce and maintain EEG burst-suppression; a longer period of ventilatory support might be anticipated with use of thiopental or other barbiturates.There are many possible permutations on the above intraoperative protocol. If the goals of the various stages are met, the exact choice of agents or techniques to attain those goals is of secondary importance. There are a limited number of small series upon which to base recommendations.In addition to pulmonary artery catheter, TEE monitoring may be useful in closed chest bypass methods. Transesophageal echocardiography allows (1) for assessment of ventricular volume and contractility (short-axis view at the papillary muscle level), (2) verification of the proper position of bypass cannulae (longitudinal view of the atria and cavae), and (3) monitoring of left and right ventricular distension during bypass (short-axis view at the papillary muscle level or four-chamber view). However, the advantages of additional information must be weighed against the risks of TEE monitoring, which include pressure necrosis of the tongue or soft tissues, esophageal injury, or cervical spine injury with head flexion. Access to the TEE probe for intraoperative manipulation should be carefully considered when positioning the patient. A reasonably accessible “tunnel” can be fashioned with the drapes and various attachments to the operating table to make for intraoperative manipulation of the TEE probe possible.Patients who have undergone recent SAH may be volume contracted, as a result of the disease process 17or recent osmotic diuresis used to treat elevated intracranial pressure or from contrast agents used during neuroimaging. Central venous access is desirable for both drug and pressure monitoring, and the incremental morbidity of placing a pulmonary artery catheter, especially with the use of ultrasound guidance for internal jugular vein cannulation, should be minimal. Care should be taken to insure that the right atrium is used as the zero reference for central pressures, but that an appropriate correction factor is introduced for monitoring cerebral perfusion pressure, either because of head placement above or below the level of the heart. In determining arterial blood levels, central venous pressure should be taken into account to most adequately indicate distal cerebral perfusion. A detailed description of measuring cardiac versus cerebral pressures is discussed elsewhere. 18The electroencephalogram may also provide a means of titrating anesthetic agents to some physiologic end point such as some clinically discernible ratio of burst-suppression. 15It must be kept in mind however, that burst-suppression does not necessarily correspond to “maximally-protective” doses of agents. Evoked potentials may also be of some use in monitoring, especially with posterior fossa lesions. 16There are several potential concerns with closed-chest femoro-femoral bypass. Myocardial protection relies on a reduction of myocardial oxygen consumption by affording hypothermia, empty ventricles, and asystole. Pharmacologic protection by cardioplegic solution is not available without aortic cross clamping. Assessing the adequacy of ventricular drainage is necessary, and this may be accomplished by monitoring central venous and pulmonary artery pressures or by direct visualization by TEE. Because of a lack of a left ventricular vent, overdistension of the left ventricle may require a conversion to open-chest bypass. Right ventricular overdistension often can be treated by venous drainage by the of an operative table to a venous A bypass with or application of to the venous using a may be used to increase venous venous return may adequate bypass flow of hypothermia, CPB, and protamine on hemostasis may result in significant There are theoretical advantages of using circuits that may allow lower systemic heparin doses and the of CPB. a discussion of such as to cerebral as well as general regarding hemostasis in bypass the is elsewhere. not used by all aneurysm surgeons, spinal subarachnoid drainage is frequently used to achieve improved brain patients are of with placement of spinal The lack of information this is related to the that such rarely and are them in the of an used This is related to the that are both placed and removed in a of normal coagulation , the catheter is during the period in which heparin is given and reversed with for the of or spinal is setting goals for safe management of CPB and of cerebral aneurysm clipping must the high of cerebral injury during both of these patients who these have cardiovascular management of CPB relatively The of cerebral injury in this setting are to those when circulatory arrest is used for cardiac lesions, with some The ability of deep hypothermia to protection from cerebral during circulatory arrest is well In there is also the of cerebral from various including blood and vascular Deep hypothermia should against as but the time of for the of injury may be before cooling and after the time periods when cannula are and systemic is or addition to the above general considerations, neurosurgical of brain injury may result from brain and of small by dissection or clip there may be of cerebral if the patient has undergone a recent even if the patient is not If such of cerebral a period is during for cerebral can during there to be an of cerebral oxygen consumption and perfusion during the rewarming might the brain by of the period of hypothermic arrest and brain regions from a SAH is most maintain relatively mean arterial pressures during rewarming after CPB, is reasonable to cerebral perfusion pressure within a normal in the patient a recent SAH or with any preoperative of or or volatile anesthetic has been to some of protection for potential of cerebral both and there is that the brain in the setting of cardiopulmonary at all that are during neurosurgical given the high morbidity of DHCA for aneurysm clipping and the of using or volatile such agents into a of the anesthetic may be is a common and appropriate that used to induce EEG burst-suppression and may cardiac that burst-suppression may not correspond to should protection even not to cardiac in the post-CPB period by without significant cardiac disease DHCA for aneurysm clipping using a fentanyl, nitrous and titrated to achieve EEG burst-suppression before CPB per the protocol and the infusion continued until after infusion continued for h until after the bypass and the infusion rate ± patients easily from bypass without there in vascular resistance and pressures, and cardiac volume returned to its and ejection have been by this same in patients with the of from of the patients from anesthesia and to at ± and a cerebral hypothermia is induced and temperature at monitoring may not cerebral appears to be from which to temperature in this setting of temperature from the nasopharynx, and pulmonary artery to brain temperature pulmonary artery not measure to the temperature used during an of may make to or has been that There however, to support this for neurosurgical DHCA in doses that will maintain adequate cerebral perfusion pressure, in to volatile such as in patients to the is a management is common after all of cerebral is common in cardiac in of chest for or , compared with patients a lower of many patients will be for neurosurgical perhaps the lower is more The lower number given the of on the from cerebral is still an high The of post-CPB and that patients DHCA will have an increase in temperature In of the with of aggressive temperature control should be , versus during CPB, remains a point of may of EEG management may result in in patient after CPB. hypothermic CPB, , in between and in patients who on bypass for more than of these to neurosurgical application of DHCA is the theoretical relatively cerebral blood flow with might cooling or of the flows and lower cerebral resistance may increase of to the cerebral circulation. greater cerebral blood flow may also with brain or intracranial with the detailed review of is the scope of this However, of from a will to make an important the ability of DHCA to therapy to some is an with patients treated with DHCA a in of patients and intracranial some of cerebral and morbidity more than of which a myocardial in 4 and in patient. The operative in these patients related to treatment in an additional morbidity in and in the advances in less of circulatory manipulation may further the to use deep hypothermic circulatory might include temporary cardiac in endovascular approaches such as aneurysm and In the however, DHCA for cerebral aneurysm clipping may be to carefully patients harboring intracranial aneurysms at treatment at such is the of the Center for Cerebrovascular Research, and for in The senior author the of and at Center of in the of the clinical for